PATENT CLAIM ANALYSIS

Application Number: 15888158
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "119000"]

Abstract:
Compounds are generally provided, along with pharmaceutical compositions including such compounds. Methods are also generally provided for inhibiting ribose 5-phosphate isomerase in a human, such as via administering to the human the pharmaceutical composition that includes such a compound. Methods are also generally provided for treating a mammal that is infected by a parasitic organism, such as via administering to the mammal the pharmaceutical composition that includes such a compound. Methods are also generally provided for forming a pharmaceutical composition.

Claim (Index 5):
The compound of  claim 1 , wherein X 5  is I.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 2.175
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15360139', '09844201', '14926607', '13990801', '14880098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7492045333402191
- 35 USC 102 Novelty (BERT): 0.4870473615538782
- Combined Prediction Score: 0.7229888161615851
- Mean Citation Score: 174.66299999999995
- Max Citation Score: 269.27924
- Similarity Product: 266.726248223958

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test